Shockwave Medical to Livestream 2023 Investor Innovation Day
04 Outubro 2023 - 9:00AM
Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the
development and commercialization of transformational technologies
for the treatment of cardiovascular disease, will host an Investor
Innovation Day on Monday, October 23, 2023, from 1:00 p.m
to 4:00 p.m. Pacific Time.
The Shockwave Investor Innovation Day will be held in hybrid
format, in person in San Francisco and online as a
simultaneous live webcast. Investors and other interested parties
may register for the webcast by visiting the news and events
section on the company's investor website at
https://ir.shockwavemedical.com.
A replay and summary materials from the presentations will also
be available online on the company website.
About Shockwave Medical, Inc.
Shockwave Medical is a leader in the development and
commercialization of novel technologies that transform the care of
underserved patients with cardiovascular disease. Its
first-of-its-kind Intravascular Lithotripsy (IVL) technology has
revolutionized the way calcium is managed during the treatment of
atherosclerotic cardiovascular disease by safely using sonic
pressure waves to disrupt challenging calcified plaque, resulting
in significantly improved patient outcomes. Through the recent
acquisition of the Reducer, which is under clinical investigation
in the U.S. and is CE Marked in the EU and UK,
Shockwave Medical plans to introduce its second transformative
technology to the interventional cardiology community. By
redistributing blood flow within the heart, the Reducer is designed
to provide relief to the millions of patients worldwide suffering
from refractory angina who have no other treatment options. Learn
more
at www.shockwavemedical.com and www.neovasc.com.
Forward-Looking Statements
This press release contains statements relating to our
expectations, activities, programs, goals, events or developments
that we expect, believe or anticipate will or may occur, which are
“forward-looking statements” within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements, other
than statements of historical facts, are statements that could be
deemed forward-looking. In some cases, you can identify these
statements by forward-looking words such as “may,” “might,” “will,”
“should,” “expects,” “plans,” “anticipates,” “believes,”
“estimates,” “predicts,” “potential,” or “continue,” and similar
expressions, and the negative of these terms. You are cautioned not
to place undue reliance on these forward-looking statements.
Forward-looking statements are only predictions based on our
current plans, expectations, estimates, and assumptions, valid only
as of the date they are made, and subject to risks and
uncertainties, some of which we are not currently aware.
Important factors that could cause our actual results to differ
materially from those indicated in the forward-looking statements
include, among others: our ability to design, develop, manufacture
and market innovative products to treat patients with challenging
medical conditions, particularly in peripheral artery disease,
coronary artery disease and aortic stenosis; our ability to
successfully execute our commercialization strategy for our
approved or cleared products; and our expected future growth,
including growth in international sales. These factors, as well as
others, are discussed in our filings with the Securities and
Exchange Commission (SEC), including in Part I, Item IA - Risk
Factors in our most recent Annual Report on Form 10-K filed with
the SEC, and in our other periodic and other reports filed with the
SEC. Except to the extent required by law, we do not undertake to
update any of these forward-looking statements after the date
hereof to conform these statements to actual results or revised
expectations.
Media Contact:Scott
Shadiow+1.317.432.9210sshadiow@shockwavemedical.com
Investor Contact:Debbie Kasterdkaster@shockwavemedical.com
Shockwave Medical (NASDAQ:SWAV)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Shockwave Medical (NASDAQ:SWAV)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024